References
- Schmitz W, Scholz H. Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na +, K+)-ATPase activity. Biochem Pharmacol 1982; 31: 3853–60
- Wilson C WM. Clinical pharmacological aspects of ascorbic acid. Ann New York Acad Sci 1975; 258: 355–76
- Wilson C WM. Ascorbic acid metabolism and the clinical factors which affect tissue saturation with ascorbic acid. Acta Vitamin Enzympl 1977; 31: 35–41
- Endresen L, Schjerven L, Rugstand HE. Tumours from a cell strain with a high content of metal-lothionein show enhanced resistance against cis-dichlorodiamineplatinum. Acta Pharmacol Toxicol 1984; 55: 183–7
- Zelazowski A J, Garvey J S, Houschele JD. In vivo and in vitro binding of platinum to metallo-thionein. Arch Biochem Biophys 1984; 229: 246–52
- Day FA. Panemangalore M, Brady RO. In vivo and ex vivo effects of copper on rat liver metal-lothionein. Proc Soc Exp Biol Med 1981; 168: 306–10
- Komune S, Ide M, Nakano T. Effects of kanamycin sulfate on cochlear potentials and potassium ion permeability through the cochlear partitions. Arch Oto-Rhino-Laryngol 1987; 49: 9–16
- Josephson L, Cantley L C, Jr. Isolation of a potent (Na.K) ATPase inhibitor from striated muscle. Biochemistry 1977; 16: 4572–8
- Audinet D, Dianoux A C, Vignais PV. Immunological studies on the beef heart natural ATPase inhibitor: localization of an antigenic determinant in the inhibitor molecule. Biochem Biophys Res Commun 1986; 137: 364–71
- Pullman M E, Monroy GC. A naturally occurring inhibitor of mitochondrial adenosine triphos-phatase. J Biol Chem 1963; 238: 3762–9
- Post RL. Cation flux across biomembranes. Academic Press, New York 1979; 3